Latest Ratings for EMN
DateFirmActionFromTo Mar 2022Piper SandlerMaintainsNeutral Jan 2022BarclaysMaintainsEqual-Weight Jan 2022Morgan StanleyMaintainsOverweight
View More Analyst Ratings for EMN
View the Latest Analyst Ratings
read more Read More
